KODIAK SCIENCES INC. (KOD) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $6.00K; Additional Paid in Capital, Common StockUSD $1.74B; Retained Earnings (Accumulated Deficit)USD $-1.68B.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $6.00K; Additional Paid in Capital, Common StockUSD $1.73B; Retained Earnings (Accumulated Deficit)USD $-1.62B.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $6.00K; Additional Paid in Capital, Common StockUSD $1.72B; Retained Earnings (Accumulated Deficit)USD $-1.56B.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $5.00K; Additional Paid in Capital, Common StockUSD $1.53B; Retained Earnings (Accumulated Deficit)USD $-1.50B.
KODIAK SCIENCES INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $6.00K | $1.74B | $-1.68B | $61.10M | 3 month · $11.61M | (m) |
| 2026-03-31 | $0.00 | $6.00K | $1.73B | $-1.62B | $112.10M | 3 month · $12.15M | (m) |
| 2025-12-31 | $0.00 | $6.00K | $1.72B | $-1.56B | $157.38M | 12 month · $58.86M | (m) |
| 2025-09-30 | $0.00 | $5.00K | $1.53B | $-1.50B | $23.69M | 3 month · $14.05M | (m) |
| 2025-06-30 | $0.00 | $5.00K | $1.51B | $-1.44B | $70.29M | 3 month · $15.64M | (m) |
| 2025-03-31 | $0.00 | $5.00K | $1.50B | $-1.39B | $108.84M | 3 month · $15.89M | (m) |
| 2024-12-31 | $0.00 | $5.00K | $1.48B | $-1.33B | $150.29M | 12 month · $60.21M | (m) |
| 2024-09-30 | $0.00 | $5.00K | $1.47B | $-1.28B | $185.37M | 3 month · $14.81M | (m) |
| 2024-06-30 | $0.00 | $5.00K | $1.46B | $-1.24B | $214.51M | 3 month · $18.38M | (m) |
| 2024-03-31 | $0.00 | $5.00K | $1.44B | $-1.20B | $241.19M | 3 month · $18.41M | (m) |
| 2023-12-31 | $0.00 | $5.00K | $1.42B | $-1.15B | $265.78M | 12 month · $88.56M | $0.00 |
| 2023-09-30 | $0.00 | $5.00K | $1.40B | $-1.09B | $302.42M | 3 month · $13.95M | $0.00 |
| 2023-06-30 | $0.00 | $5.00K | $1.38B | $-1.04B | $338.48M | 3 month · $25.80M | $0.00 |
| 2023-03-31 | $0.00 | $5.00K | $1.36B | $-962.82M | $392.59M | 3 month · $25.98M | $-96.00K |
| 2022-12-31 | $0.00 | $5.00K | $1.33B | $-892.04M | $436.17M | 12 month · $106.03M | $-1.31M |
| 2022-09-30 | (m) | $5.00K | $1.30B | $-821.59M | $479.53M | 3 month · $26.18M | $-2.50M |
| 2022-06-30 | (m) | $5.00K | $1.28B | $-744.55M | $530.93M | 3 month · $25.98M | $-1.87M |
| 2022-03-31 | $0.00 | $5.00K | $1.25B | $-653.93M | $597.38M | 3 month · $28.09M | (m) |
| 2021-12-31 | $0.00 | $5.00K | $1.22B | $-558.22M | $663.32M | 12 month · $61.38M | $0.00 |
| 2021-09-30 | (m) | $5.00K | $1.19B | $-465.05M | $726.32M | 3 month · $12.38M | (m) |
| 2021-06-30 | (m) | $5.00K | $1.18B | $-397.53M | $779.43M | 3 month · $11.09M | $0.00 |
| 2021-03-31 | (m) | $5.00K | $1.16B | $-341.67M | $821.68M | 3 month · $9.93M | $18.00K |
| 2020-12-31 | $0.00 | $5.00K | $1.15B | $-291.23M | $860.75M | 12 month · $30.67M | $53.00K |
| 2020-09-30 | (m) | $5.00K | $526.17M | $-244.64M | $281.78M | 3 month · $8.24M | $245.00K |
| 2020-06-30 | (m) | $5.00K | $517.12M | $-208.52M | $309.20M | 3 month · $6.89M | $594.00K |
| 2020-03-31 | (m) | $5.00K | $509.72M | $-182.52M | $327.69M | 3 month · $6.08M | $489.00K |
| 2019-12-31 | (m) | $5.00K | $503.48M | $-158.13M | $345.36M | 12 month · $6.11M | $10.00K |
| 2019-09-30 | (m) | $4.00K | $202.18M | $-142.51M | $59.69M | 3 month · $1.77M | $19.00K |
| 2019-06-30 | (m) | $4.00K | $200.14M | $-130.13M | $70.02M | 3 month · $1.24M | $12.00K |
| 2019-03-31 | (m) | $4.00K | $198.84M | $-118.75M | $80.09M | 3 month · $1.16M | $6.00K |
| 2018-12-31 | (m) | $4.00K | $197.59M | $-110.77M | $86.83M | 12 month · $2.76M | (m) |
| 2018-09-30 | (m) | $1.00K | $2.27M | $-96.10M | $-93.83M | 3 month · $800.00K | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) | $-84.23M | 3 month · $748.00K | (m) |
| 2018-03-31 | (m) | (m) | (m) | (m) | $-77.57M | 3 month · $92.00K | (m) |
| 2017-12-31 | (m) | $1.00K | $584.00K | $-69.32M | $-68.74M | 12 month · $275.00K | (m) |
| 2016-12-31 | (m) | (m) | (m) | (m) | $-41.08M | 12 month · $272.00K | (m) |
| 2015-12-31 | (m) | (m) | (m) | (m) | $-24.24M | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |